Current Research Studies

An Open-Label, Expanded Access Protocol for Boys with Duchenne Muscular Dystrophy who Have Completed the Long-Term Extension (VBP15-LTE) or VBP15-004 Studies

Vamorolone EAP VBP15-EAP

What is the goal of the study?

This protocol is to provide continued access to Vamorolone for subjects in the United States who have completed the VBP15-LTE or VBP15-004 protocols (and are thereby ineligible to enroll in another trial of Vamorolone therapy), during the time that VBP15-004 is ongoing, and while a new drug application for Vamorolone is under preparation and review.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: